Stellate Ganglion Block for Prevention of Post Mastectomy Depression (NCT06263907) | Clinical Trial Compass
RecruitingNot Applicable
Stellate Ganglion Block for Prevention of Post Mastectomy Depression
Egypt140 participantsStarted 2024-03-01
Plain-language summary
Complications after mastectomy include chronic pain and depression.
Who can participate
Age range21 Years – 65 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female patients
* Age ranging from 18 to 65 years
* American Society of Anesthesiologists (ASA) no more than II
* Had unilateral cancer breast
* Scheduled to do unilateral modified radical mastectomy
Exclusion Criteria:
* Pregnant female
* Existing Horner syndrome
* Had any neuromuscular disease
* Had allergy to local anesthetics
* History of use of analgesics
* Had any deformity or a previous surgery in the neck or ipsilateral arm or breast
* Had any contraindication to the procedure (coagulation disorders, local infection, sepsis)
* Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary or hemodynamic disorders)
* History of psychotic disorder including depression, bipolar disorder or personality disorder
* Patient with Beck Depression Inventory (BDI) score more than 13